Okomera
About:
Okomera is a biotech start-up that accelerates access to improved, precision-based cancer therapies.
Website: https://www.okomera.com/
Twitter/X: Okomera1
Top Investors: Bpifrance, Berkeley SkyDeck Fund, AGORANOV, Resonance, Polytechnique Ventures
Description:
Okomera is a biotech start-up that accelerates access to more effective, precision-based cancer medicines. It pioneered the automation and downsizing of individualized tumor biopsy research.
Total Funding Amount:
11.7M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2020-01-01
Founders:
Aimee Wessel, Charles Baroud, Raphaël Tomasi, Sandra Jernström
Number of Employees:
1-10
Last Funding Date:
2024-10-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai